FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:1731-1738 June 16, 1994 Number 24 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article PubMed Citation

Hyperthyroidism is common, affecting approximately 2 percent of women and 0.2 percent of men¹. There are three principal treatments -- antithyroid drugs, radioiodine, and surgery -- all of which are effective, but opinions differ about the indications for them² because no single treatment regularly results in permanent euthyroidism.

Investigation of Hyperthyroidism

When hyperthyroidism is suspected, the diagnosis should be confirmed by measurement of serum thyrotropin and total or free thyroxine, which are usually present in low and high concentrations, respectively (Figure 1)³. If the thyrotropin level is low but the thyroxine level is normal, serum triiodothyronine should be measured, . . . [Full Text of this Article]

Antithyroid Drugs

Indications for Antithyroid-Drug Therapy and Treatment Regimens

Side Effects

Outcome of Treatment

-Adrenergic-Antagonist Drugs

Inorganic Iodide

Radioiodine Therapy

Indications and Regimens

Post-Treatment Thyroid Function

Other Side Effects and Adjunctive Treatment

Ophthalmopathy

Cancer and Teratogenesis

Subtotal Thyroidectomy

Preparation and Adverse Effects

Postoperative Thyroid Function

Management of Toxic Adenoma or Toxic Nodular Goiter

Management of Hyperthyroidism Caused by Thyroiditis

Management of Hyperthyroidism in Pregnancy

Treatment of Thyrotoxic Crisis

Summary

Source Information

From the Department of Medicine, University of Birmingham, Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, United Kingdom, where reprint requests should be addressed to Dr. Franklyn.

References

This article has been cited by other articles:

• Metso, S., Jaatinen, P., Huhtala, H., Auvinen, A., Oksala, H., Salmi, J. (2007). Increased Cardiovascular and Cancer Mortality after Radioiodine Treatment for Hyperthyroidism. J. Clin. Endocrinol. Metab. 92: 2190-2196 [Abstract] [Full Text]  
• Walter, M. A, Briel, M., Christ-Crain, M., Bonnema, S. J, Connell, J., Cooper, D. S, Bucher, H. C, Muller-Brand, J., Muller, B. (2007). Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials. BMJ 334: 514-514 [Abstract] [Full Text]  
• Osman, F., Franklyn, J. A., Holder, R. L., Sheppard, M. C., Gammage, M. D. (2007). Cardiovascular Manifestations of Hyperthyroidism Before and After Antithyroid Therapy: A Matched Case-Control Study. J Am Coll Cardiol 49: 71-81 [Abstract] [Full Text]  
• (2006). Radioiodine therapy for hyperthyroidism. DTB 44: 44-48 [Abstract] [Full Text]  
• Cohen, S. P., Kent, C. (2005). Pronounced unexplained preoperative tachycardia heralding serious cardiac events: a series of three cases: [Tachycardie preoperatoire prononcee, inexpliquee, prodrome d'evenements cardiaques serieux : une serie de trois cas]. Canadian J. Anesthesia 52: 858-863 [Abstract] [Full Text]  
• Birrell, G, Cheetham, T (2004). Juvenile thyrotoxicosis; can we do better?. Arch. Dis. Child. 89: 745-750 [Abstract] [Full Text]  
• Brokken, L. J. S., Wiersinga, W. M., Prummel, M. F. (2003). Thyrotropin Receptor Autoantibodies Are Associated with Continued Thyrotropin Suppression in Treated Euthyroid Graves' Disease Patients. J. Clin. Endocrinol. Metab. 88: 4135-4138 [Abstract] [Full Text]  
• Ginsberg, J. (2003). Diagnosis and management of Graves' disease. CMAJ 168: 575-585 [Abstract] [Full Text]  
• Brokken, L. J. S., Scheenhart, J. W. C., Wiersinga, W. M., Prummel, M. F. (2001). Suppression of Serum TSH by Graves' Ig: Evidence for a Functional Pituitary TSH Receptor. J. Clin. Endocrinol. Metab. 86: 4814-4817 [Abstract] [Full Text]  
• Allahabadia, A., Daykin, J., Sheppard, M. C., Gough, S. C. L., Franklyn, J. A. (2001). Radioiodine Treatment of Hyperthyroidism--Prognostic Factors for Outcome. J. Clin. Endocrinol. Metab. 86: 3611-3617 [Abstract] [Full Text]  
• Lacey, N A, Jones, A, Clarke, S E M (2001). Role of radionuclide imaging in hyperthyroid patients with no clinical suspicion of nodules. Br. J. Radiol. 74: 486-489 [Abstract] [Full Text]  
• Prummel, M. F., Brokken, L. J. S., Meduri, G., Misrahi, M., Bakker, O., Wiersinga, W. M. (2000). Expression of the Thyroid-Stimulating Hormone Receptor in the Folliculo-Stellate Cells of the Human Anterior Pituitary. J. Clin. Endocrinol. Metab. 85: 4347-4353 [Abstract] [Full Text]  
• Weetman, A. P. (2000). Graves' Disease. NEJM 343: 1236-1248 [Full Text]  
• Lazar, L., Kalter-Leibovici, O., Pertzelan, A., Weintrob, N., Josefsberg, Z., Phillip, M. (2000). Thyrotoxicosis in Prepubertal Children Compared with Pubertal and Postpubertal Patients. J. Clin. Endocrinol. Metab. 85: 3678-3682 [Abstract] [Full Text]  
• Allahabadia, A., Daykin, J., Holder, R. L., Sheppard, M. C., Gough, S. C. L., Franklyn, J. A. (2000). Age and Gender Predict the Outcome of Treatment for Graves' Hyperthyroidism. J. Clin. Endocrinol. Metab. 85: 1038-1042 [Abstract] [Full Text]  
• Rivkees, S. A., Sklar, C., Freemark, M. (1998). The Management of Graves' Disease in Children, with Special Emphasis on Radioiodine Treatment. J. Clin. Endocrinol. Metab. 83: 3767-3776 [Full Text]  
• Roti, E., Braverman, L. E., DeGroot, L. J. (1998). TSH Receptor Antibody Measurement in the Diagnosis and Management of Graves' Disease Is Rarely Necessaryb. J. Clin. Endocrinol. Metab. 83: 3781-3784 [Full Text]  
• Hermus, A. R., Huysmans, D. A. (1998). Treatment of Benign Nodular Thyroid Disease. NEJM 338: 1438-1447 [Full Text]  
• Rittmaster, R. S., Abbott, E. C., Douglas, R., Givner, M. L., Lehmann, L., Reddy, S., Salisbury, S. R., Shlossberg, A. H., Tan, M. H., York, S. E. (1998). Effect of Methimazole, with or without L-Thyroxine, on Remission Rates in Graves' Disease. J. Clin. Endocrinol. Metab. 83: 814-818 [Abstract] [Full Text]  
• Chiovato, L., Fiore, E., Vitti, P., Rocchi, R., Rago, T., Dokic, D., Latrofa, F., Mammoli, C., Lippi, F., Ceccarelli, C., Pinchera, A. (1998). Outcome of Thyroid Function in Graves' Patients Treated with Radioiodine: Role of Thyroid-Stimulating and Thyrotropin-Blocking Antibodies and of Radioiodine-Induced Thyroid Damage. J. Clin. Endocrinol. Metab. 83: 40-46 [Abstract] [Full Text]  
• Lucas, A., Salinas, I., Rius, F., Pizarro, E., Granada, M.L., Foz, M., SanmartI, A. (1997). Medical Therapy of Graves' Disease: Does Thyroxine Prevent Recurrence of Hyperthyroidism?. J. Clin. Endocrinol. Metab. 82: 2410-2413 [Abstract] [Full Text]  
• Glaser, N. S., Styne, D. M. (1997). Predictors of Early Remission of Hyperthyroidism in Children. J. Clin. Endocrinol. Metab. 82: 1719-1726 [Abstract] [Full Text]  
• McIver, B., Rae, P., Beckett, G., Wilkinson, E., Gold, A., Toft, A. (1996). Lack of Effect of Thyroxine in Patients with Graves' Hyperthyroidism Who Are Treated with an Antithyroid Drug. NEJM 334: 220-224 [Abstract] [Full Text]  
• (1995). The practical management of thyroid disease in pregnancy. DTB 33: 75-77 [Abstract] [Full Text]